Rating History for GlaxoSmithKline (GSK) by Citi

More Stocks Rated by Citi | Latest Ratings for GSK
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/5/2017 N/A Downgrade Neutral
(Buy)		 N/A
(N/A)		 42.77
(52.49)		 22.73% Details